CompletedPhase 3NCT00003888
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Jan B. Vermorken, MD, PhDUniversity Hospital, Antwerp
- Intervention
- cisplatin(drug)
- Enrollment
- 359 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 1999 – 2015
Study locations (30)
- Landeskrankenhaus/Universitatskliniken Graz, Graz, Austria
- Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
- Kaiser Franz Josef Hospital, Vienna, Austria
- Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
- Institut Jules Bordet, Brussels, Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- Centre Hospitalier Regional de la Citadelle, Liège, Belgium
- Clinique Universitaire De Mont-Godinne, Mont-Godinne Yvoir, Belgium
- Institute of Oncology and Radiology of Serbia, Belgrade, Federal Republic of Yugoslavia
- CHR de Besancon - Hopital Jean Minjoz, Besançon, France
- Centre Oscar Lambret, Lille, France
- Centre Hospital Regional Universitaire de Limoges, Limoges, France
- Centre Leon Berard, Lyon, France
- CHR Hotel Dieu, Nantes, France
- CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003888 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →